97 Idnt PPTs View free & download

The IDNT Trial PowerPoint PPT Presentation

The IDNT Trial - The IDNT Trial Reference Lewis EJ, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

The IDNT Trial Reference Lewis EJ, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

| PowerPoint PPT presentation | free to view

IDNT Irbesartan Diabetic Nephropathy Trial PowerPoint PPT Presentation

IDNT Irbesartan Diabetic Nephropathy Trial - Title: IDNT Irbesartan Diabetic Nephropathy Trial Author: marka Last modified by: FDA.CDER Created Date: 4/19/2002 7:07:40 PM Document presentation format

Title: IDNT Irbesartan Diabetic Nephropathy Trial Author: marka Last modified by: FDA.CDER Created Date: 4/19/2002 7:07:40 PM Document presentation format

| PowerPoint PPT presentation | free to view

CPG on HPT - INCIPIENT NEPHROPATHY. Hyperfiltration, microalbuminuria, rising blood pressure. PRECLINICAL ... INCIPIENT NEPHROPATHY. PRECLINICAL. NEPHROPATHY. IRMA 2. IDNT ...

INCIPIENT NEPHROPATHY. Hyperfiltration, microalbuminuria, rising blood pressure. PRECLINICAL ... INCIPIENT NEPHROPATHY. PRECLINICAL. NEPHROPATHY. IRMA 2. IDNT ...

| PowerPoint PPT presentation | free to view

A1260830706zBGtn PowerPoint PPT Presentation

A1260830706zBGtn - If a woman has a normal BP by age 65, what is her risk of developing ... ELSA. LIFE/DM. NICOLE. PREVENT. IDNT2. SCOPE. Older trials active. HOPE. VALUE ...

If a woman has a normal BP by age 65, what is her risk of developing ... ELSA. LIFE/DM. NICOLE. PREVENT. IDNT2. SCOPE. Older trials active. HOPE. VALUE ...

| PowerPoint PPT presentation | free to view

The Irbesartan in Diabetic Nephropathy Trial PowerPoint PPT Presentation

The Irbesartan in Diabetic Nephropathy Trial - The differences between the treatment groups were not statistically significant, ... Composite of a doubling of serum creatinine, end stage renal disease, or death ...

The differences between the treatment groups were not statistically significant, ... Composite of a doubling of serum creatinine, end stage renal disease, or death ...

| PowerPoint PPT presentation | free to view

Angiotensin Receptor Blockers and Renoprotection in Diabetes PowerPoint PPT Presentation

Angiotensin Receptor Blockers and Renoprotection in Diabetes - A 54 y/o BF with DM, HTN and elevated protein/creatinine ratio on ... de Gasparo et al. Pharmacology Toxicology, 1998. Mechanism of Action of. ACE I and ARBs ...

A 54 y/o BF with DM, HTN and elevated protein/creatinine ratio on ... de Gasparo et al. Pharmacology Toxicology, 1998. Mechanism of Action of. ACE I and ARBs ...

| PowerPoint PPT presentation | free to view

Hypertension and Chronic Kidney Disease PowerPoint PPT Presentation

Hypertension and Chronic Kidney Disease - A. one in fifty. B. one in twenty. C. one in eight. D. one in four ... INFLAMMATION plus CaP deposition. CV DISEASE AND DEATH. CKD/ESRD. ANEMIA. LVH/CHF. LIPIDS ...

A. one in fifty. B. one in twenty. C. one in eight. D. one in four ... INFLAMMATION plus CaP deposition. CV DISEASE AND DEATH. CKD/ESRD. ANEMIA. LVH/CHF. LIPIDS ...

| PowerPoint PPT presentation | free to view

Treatment of Diabetic Nephropathy and Proteinuria Background - Treatment of Diabetic Nephropathy and Proteinuria Background

Treatment of Diabetic Nephropathy and Proteinuria Background

| PowerPoint PPT presentation | free to view

APPROACH TO A PATIENT WITH PROTEINURIC RENAL DISEASE PowerPoint PPT Presentation

APPROACH TO A PATIENT WITH PROTEINURIC RENAL DISEASE - APPROACH TO A PATIENT WITH PROTEINURIC RENAL DISEASE PHYSIOLOGY AND PATHOPHYSIOLOGY OF PROTEIN EXCRETION Physiology/Pathophysiology Protein flow through renal ...

APPROACH TO A PATIENT WITH PROTEINURIC RENAL DISEASE PHYSIOLOGY AND PATHOPHYSIOLOGY OF PROTEIN EXCRETION Physiology/Pathophysiology Protein flow through renal ...

| PowerPoint PPT presentation | free to view

Modifiable Risk Factors Associated with Adverse Cardiovascular and Renal Events in Chronic Kidney Di PowerPoint PPT Presentation

Modifiable Risk Factors Associated with Adverse Cardiovascular and Renal Events in Chronic Kidney Di - Goodfriend et al. N Engl J Med. 1996;334:1649-1655. Bradykinin. ACE. Angiotensin I ... Bradykinin. Inactive Fragments. Ang II. Ang I. Angiotensin. ACEI. Renin ...

Goodfriend et al. N Engl J Med. 1996;334:1649-1655. Bradykinin. ACE. Angiotensin I ... Bradykinin. Inactive Fragments. Ang II. Ang I. Angiotensin. ACEI. Renin ...

| PowerPoint PPT presentation | free to view

Synergistic actions of hypertension and dyslipidemia on endothelial function PowerPoint PPT Presentation

Synergistic actions of hypertension and dyslipidemia on endothelial function - Title: PowerPoint Presentation Author: Medical Education Consultants, LLC Last modified by: William Tryon Created Date: 6/7/2004 4:56:07 PM Document presentation format

Title: PowerPoint Presentation Author: Medical Education Consultants, LLC Last modified by: William Tryon Created Date: 6/7/2004 4:56:07 PM Document presentation format

| PowerPoint PPT presentation | free to view

CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATIO PowerPoint PPT Presentation

CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATIO - Over 13 million Americans are estimated to have chronic kidney disease (CKD) ... Estimated (eGFR) (ml/min/1.73 m2) calculated by simplified MDRD equation (Levey ...

Over 13 million Americans are estimated to have chronic kidney disease (CKD) ... Estimated (eGFR) (ml/min/1.73 m2) calculated by simplified MDRD equation (Levey ...

| PowerPoint PPT presentation | free to view

Angiotensin II Interaction With Secondary Mediators PowerPoint PPT Presentation

Angiotensin II Interaction With Secondary Mediators - Endothelial dysfunction and smooth muscle activation. NO Local mediators ... Erectile Dysfunction (n=1500) Health Economics (n=7000) Blood Markers (n=12,000) ...

Endothelial dysfunction and smooth muscle activation. NO Local mediators ... Erectile Dysfunction (n=1500) Health Economics (n=7000) Blood Markers (n=12,000) ...

| PowerPoint PPT presentation | free to view

ENFERMEDAD RENAL CRONICA PowerPoint PPT Presentation

ENFERMEDAD RENAL CRONICA - ENFERMEDAD RENAL CRONICA Se define como una anomal a estructural o funcional del ri n de duraci n mayor a tres meses Reducci n Clearence

ENFERMEDAD RENAL CRONICA Se define como una anomal a estructural o funcional del ri n de duraci n mayor a tres meses Reducci n Clearence

| PowerPoint PPT presentation | free to download

Assessing Surrogacy in CKD* PowerPoint PPT Presentation

Assessing Surrogacy in CKD* - AASK Trial treatment with blood pressure lowering, ramipril, metoprolol, or amlodipine ... Ramirpril vs. Amlodipine. AASK (hypertensive nephro.) 18% 26% ESRD ...

AASK Trial treatment with blood pressure lowering, ramipril, metoprolol, or amlodipine ... Ramirpril vs. Amlodipine. AASK (hypertensive nephro.) 18% 26% ESRD ...

| PowerPoint PPT presentation | free to download

CASE PRESENTATION: Diabetes Mellitus Type 2, Hypertension, Proteinuria, Edema' PowerPoint PPT Presentation

CASE PRESENTATION: Diabetes Mellitus Type 2, Hypertension, Proteinuria, Edema' - Division of Nephrology and Hypertension. Director CME, Department of Medicine ... Lungs Clear to auscultation. CVS RR, Rate 82, S1 S2 normal. No S3, S4, murmurs ...

Division of Nephrology and Hypertension. Director CME, Department of Medicine ... Lungs Clear to auscultation. CVS RR, Rate 82, S1 S2 normal. No S3, S4, murmurs ...

| PowerPoint PPT presentation | free to view

PowerPoint Sunusu PowerPoint PPT Presentation

PowerPoint Sunusu - Title: PowerPoint Sunusu Author: Yunus Erdem Last modified by: user1 Created Date: 5/9/2005 8:37:29 AM Document presentation format: Ekran G sterisi

Title: PowerPoint Sunusu Author: Yunus Erdem Last modified by: user1 Created Date: 5/9/2005 8:37:29 AM Document presentation format: Ekran G sterisi

| PowerPoint PPT presentation | free to download

DIURETICS: - Davidoff 09 DIURETICS: (know those used to Tx hypertension and HF) Thiazide diuretics: hydrochlorothiazide Loop diuretics: furosemide, ethacrynic acid

Davidoff 09 DIURETICS: (know those used to Tx hypertension and HF) Thiazide diuretics: hydrochlorothiazide Loop diuretics: furosemide, ethacrynic acid

| PowerPoint PPT presentation | free to download

Diabetic nephropathy PowerPoint PPT Presentation

Diabetic nephropathy - Diabetic nephropathy 12/21 Nephro Fellow 1

Diabetic nephropathy 12/21 Nephro Fellow 1

| PowerPoint PPT presentation | free to view

TREATMENT OF COMPLICATED HYERTENSION Joseph L. Izzo Jr, MD Professor of Medicine, Pharmacology, and PowerPoint PPT Presentation

TREATMENT OF COMPLICATED HYERTENSION Joseph L. Izzo Jr, MD Professor of Medicine, Pharmacology, and - ACC/AHA Post-MI Guideline, BHAT, SAVE, Capricorn, EPHESUS, VALIANT ... in women) Increased aortic stiffness can be structural or functional ...

ACC/AHA Post-MI Guideline, BHAT, SAVE, Capricorn, EPHESUS, VALIANT ... in women) Increased aortic stiffness can be structural or functional ...

| PowerPoint PPT presentation | free to view

CHRONIC KIDNEY DISEAS PowerPoint PPT Presentation

CHRONIC KIDNEY DISEAS - CHRONIC KIDNEY DISEAS Hisham Abdelwahab MRCP U.K MMed/SCI Common presentation of CKD Asymptomatic urine abnormalities : proteinuria/ hgaematuria Nephritic/Nephrotic ...

CHRONIC KIDNEY DISEAS Hisham Abdelwahab MRCP U.K MMed/SCI Common presentation of CKD Asymptomatic urine abnormalities : proteinuria/ hgaematuria Nephritic/Nephrotic ...

| PowerPoint PPT presentation | free to view

HYPERTENSION When, what, co-morbid conditions ? PowerPoint PPT Presentation

HYPERTENSION When, what, co-morbid conditions ? - Title: HYPERTENSION Recent Tirals Update Subject: Recent HT Trials Author: George Mangos Keywords: target, observational data Last modified by: George

Title: HYPERTENSION Recent Tirals Update Subject: Recent HT Trials Author: George Mangos Keywords: target, observational data Last modified by: George

| PowerPoint PPT presentation | free to view

Prevention and Treatment of Cardiovascular and Renal Disease in Hypertensive Patients With Type 2 Di PowerPoint PPT Presentation

Prevention and Treatment of Cardiovascular and Renal Disease in Hypertensive Patients With Type 2 Di - Cardiovascular and Renal Disease. in Hypertensive Patients With. Type 2 Diabetes ... neurologic score, high BP or ischemic heart disease, smoking, and diuretic use; ...

Cardiovascular and Renal Disease. in Hypertensive Patients With. Type 2 Diabetes ... neurologic score, high BP or ischemic heart disease, smoking, and diuretic use; ...

| PowerPoint PPT presentation | free to view

Hypertension PowerPoint PPT Presentation

Hypertension - Unbearable side effects: extreme orthostatic hypotension, ... left ventricle hypertrophy; ECG, electrocardiogram; MI, myocardial ischemia, CV, cardiovascular. ...

Unbearable side effects: extreme orthostatic hypotension, ... left ventricle hypertrophy; ECG, electrocardiogram; MI, myocardial ischemia, CV, cardiovascular. ...

| PowerPoint PPT presentation | free to view

Diabetic%20Nephropathy PowerPoint PPT Presentation

Diabetic%20Nephropathy - Identify goals for diabetes therapy in patients with CKD with emphasis on ... From the saliva of the gila monster. Incretin mimetic. Enhances beta cell insulin ...

Identify goals for diabetes therapy in patients with CKD with emphasis on ... From the saliva of the gila monster. Incretin mimetic. Enhances beta cell insulin ...

| PowerPoint PPT presentation | free to download

Rales and other recent trials in heart failure PowerPoint PPT Presentation

Rales and other recent trials in heart failure - ... Val-HeFT y CHARM-Added studies tienen resultados similares. ... The 4D Study. Presented during the Last minute session: Recent results from clinical trials.

... Val-HeFT y CHARM-Added studies tienen resultados similares. ... The 4D Study. Presented during the Last minute session: Recent results from clinical trials.

| PowerPoint PPT presentation | free to download

RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILT PowerPoint PPT Presentation

RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILT - Amlodipine. Chlorthalidone. 6-year rates per 100 (se) & total events / N. End Stage Renal Disease by Baseline Diabetes & Treatment Amlodipine vs Chlorthalidone ...

Amlodipine. Chlorthalidone. 6-year rates per 100 (se) & total events / N. End Stage Renal Disease by Baseline Diabetes & Treatment Amlodipine vs Chlorthalidone ...

| PowerPoint PPT presentation | free to view

RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILT - Hypertension is the second most common cause of end-stage renal disease (ESRD) in the US ... Estimated GFR was higher at the end of the study in patients randomized to ...

Hypertension is the second most common cause of end-stage renal disease (ESRD) in the US ... Estimated GFR was higher at the end of the study in patients randomized to ...

| PowerPoint PPT presentation | free to view

The Importance of Blood Pressure Control in Diabetes PowerPoint PPT Presentation

The Importance of Blood Pressure Control in Diabetes - Favors Lisinopril. 1.11 (0.88-1.38) Favors Chlorthalidone. Amlodipine. Lisinopril. ALLHAT: Secondary Endpoints: ESRD. ALLHAT Collaborative Research Group. JAMA. ...

Favors Lisinopril. 1.11 (0.88-1.38) Favors Chlorthalidone. Amlodipine. Lisinopril. ALLHAT: Secondary Endpoints: ESRD. ALLHAT Collaborative Research Group. JAMA. ...

| PowerPoint PPT presentation | free to view

Metabolic Syndrome PowerPoint PPT Presentation

Metabolic Syndrome - Jab Mein Thaa, Tab Guru Nahin Aub Guru Hai, Mein Nahin Sab Andhiyara Mit Gaya Jab Deepak Dekhya Mahin When

Jab Mein Thaa, Tab Guru Nahin Aub Guru Hai, Mein Nahin Sab Andhiyara Mit Gaya Jab Deepak Dekhya Mahin When

| PowerPoint PPT presentation | free to download

HYPERTENSION When, what, co-morbid conditions ? - Title: HYPERTENSION Recent Tirals Update Subject: Recent HT Trials Author: George Mangos Keywords: target, observational data Last modified by: George

Title: HYPERTENSION Recent Tirals Update Subject: Recent HT Trials Author: George Mangos Keywords: target, observational data Last modified by: George

| PowerPoint PPT presentation | free to view

Parmi les marqueurs du risque cardiovasculaire PowerPoint PPT Presentation

Parmi les marqueurs du risque cardiovasculaire - Parmi les marqueurs du risque cardiovasculaire ALBUMINURIE et PROTEINURIE FONCTION RENALE DETERMINATION OF ALBUMINURIA 24-h urine collection Night-time urine ...

Parmi les marqueurs du risque cardiovasculaire ALBUMINURIE et PROTEINURIE FONCTION RENALE DETERMINATION OF ALBUMINURIA 24-h urine collection Night-time urine ...

| PowerPoint PPT presentation | free to view

DIABETE ASPECTS NEPHROLOGIQUES PowerPoint PPT Presentation

DIABETE ASPECTS NEPHROLOGIQUES - 2. COMPLICATIONS CARDIO VASCULAIRES / INCIDENCE DE LA NEPHROPATHIE. 3. ... En France, le diab te repr sente 15 % environ des causes de mises en dialyse. ...

2. COMPLICATIONS CARDIO VASCULAIRES / INCIDENCE DE LA NEPHROPATHIE. 3. ... En France, le diab te repr sente 15 % environ des causes de mises en dialyse. ...

| PowerPoint PPT presentation | free to download

Kijk naar de nieren en leer over het hart PowerPoint PPT Presentation

Kijk naar de nieren en leer over het hart - Kijk naar de nieren en leer over het hart Bart De Moor namens Hilde Keuleers, Koen Stas en Johan vanwalleghem Virga Jesseziekenhuis Casus 1 Man 55 jaar oud Werkt bij ...

Kijk naar de nieren en leer over het hart Bart De Moor namens Hilde Keuleers, Koen Stas en Johan vanwalleghem Virga Jesseziekenhuis Casus 1 Man 55 jaar oud Werkt bij ...

| PowerPoint PPT presentation | free to view

OUR VISION To be a globally-acknowledged centre of excellence for clinical care, education PowerPoint PPT Presentation

OUR VISION To be a globally-acknowledged centre of excellence for clinical care, education - OUR VISION To be a globally-acknowledged centre of excellence for clinical care, education & training, and research in diabetology and endocrinology.

OUR VISION To be a globally-acknowledged centre of excellence for clinical care, education & training, and research in diabetology and endocrinology.

| PowerPoint PPT presentation | free to view

N - N phropathie diab tique

N phropathie diab tique

| PowerPoint PPT presentation | free to view

Chronic Kidney Disease: A Silent Epidemic Part 1 PowerPoint PPT Presentation

Chronic Kidney Disease: A Silent Epidemic Part 1 - US Renal Data System, 2000 Atlas of ESRD in the United States. ... Inpatient Days among Elderly Medicare Pts with CKD in the United States. ...

US Renal Data System, 2000 Atlas of ESRD in the United States. ... Inpatient Days among Elderly Medicare Pts with CKD in the United States. ...

| PowerPoint PPT presentation | free to view

ESH/ESC Guidelines: PowerPoint PPT Presentation

ESH/ESC Guidelines: - Definitions and Classification of BP Levels (mmHg) Category Optimal Normal High normal Grade 1 hypertension (mild) Grade 2 hypertension (moderate) Grade 3 ...

Definitions and Classification of BP Levels (mmHg) Category Optimal Normal High normal Grade 1 hypertension (mild) Grade 2 hypertension (moderate) Grade 3 ...

| PowerPoint PPT presentation | free to view

Nutritional Management of CKD Patients Dr. Bill McClellan wmcclelsph.emory.edu PowerPoint PPT Presentation

Nutritional Management of CKD Patients Dr. Bill McClellan wmcclelsph.emory.edu - ... through a screening program for high blood pressure that was performed in 14 US ... phosphorus in your blood, you should eat fewer foods that are high in ...

... through a screening program for high blood pressure that was performed in 14 US ... phosphorus in your blood, you should eat fewer foods that are high in ...

| PowerPoint PPT presentation | free to view

Excr - Excr tion urinaire d Albumine (EUA) Microalbuminuries Prot inuries d Hyperfiltration DCEM Pole SIII P. ZAOUI Le signe de l anomalie de la ...

Excr tion urinaire d Albumine (EUA) Microalbuminuries Prot inuries d Hyperfiltration DCEM Pole SIII P. ZAOUI Le signe de l anomalie de la ...

| PowerPoint PPT presentation | free to download

Blood Pressure Classification - Blood Pressure Classification

Blood Pressure Classification

| PowerPoint PPT presentation | free to view

Blood Pressure Lowering Treatment Trialists Collaboration Second cycle of overview analyses PowerPoint PPT Presentation

Blood Pressure Lowering Treatment Trialists Collaboration Second cycle of overview analyses - Established in 1995 by the principal investigators of ongoing ... diuretic/beta-blocker. 141. 758. UKPDS-HDS. 6031. 47430. Total. 897. 4418. STOP-2. 698. 10985 ...

Established in 1995 by the principal investigators of ongoing ... diuretic/beta-blocker. 141. 758. UKPDS-HDS. 6031. 47430. Total. 897. 4418. STOP-2. 698. 10985 ...

| PowerPoint PPT presentation | free to view

Diabetes Mellitus: Discuss PowerPoint PPT Presentation

Diabetes Mellitus: Discuss - Title: MAPA e Diabetes Subject: Tese Paulo Author: Sandra Roberta G Ferreira Keywords: MAPA Hipertens o Diabetes DM Description: Disc Med Preventiva

Title: MAPA e Diabetes Subject: Tese Paulo Author: Sandra Roberta G Ferreira Keywords: MAPA Hipertens o Diabetes DM Description: Disc Med Preventiva

| PowerPoint PPT presentation | free to view

CONFUSING MESSAGES FROM GUIDELINES AND THE HYPERTENSION TREATMENT TRIALS PowerPoint PPT Presentation

CONFUSING MESSAGES FROM GUIDELINES AND THE HYPERTENSION TREATMENT TRIALS - regime based on a CCB /- an ACE inhibitor ... ACE inhibitors. B-Blockers. Calcium channel blockers. Vasodilators 1 Agent without thiazide ...

regime based on a CCB /- an ACE inhibitor ... ACE inhibitors. B-Blockers. Calcium channel blockers. Vasodilators 1 Agent without thiazide ...

| PowerPoint PPT presentation | free to view

Ahmed M. Awad, D.O. Assistant Professor of Medicine University MissouriKansas City Director of outpa PowerPoint PPT Presentation

Ahmed M. Awad, D.O. Assistant Professor of Medicine University MissouriKansas City Director of outpa - Spot. Collection ( g/mg Cr) Timed. Collection ( g/min) Macro- Normo- Albuminuria ... Patients with 3 g of protein had 2.7 folds higher risk for heart failure and ...

Spot. Collection ( g/mg Cr) Timed. Collection ( g/min) Macro- Normo- Albuminuria ... Patients with 3 g of protein had 2.7 folds higher risk for heart failure and ...

| PowerPoint PPT presentation | free to view

St - Age (men 55 yr; women 65 yr) Family history of premature CVD ... TROPHY: Kaplan-Meier Curves. of New Onset Clinical Hypertension. LIFESTYLE MODIFICATIONS ...

Age (men 55 yr; women 65 yr) Family history of premature CVD ... TROPHY: Kaplan-Meier Curves. of New Onset Clinical Hypertension. LIFESTYLE MODIFICATIONS ...

| PowerPoint PPT presentation | free to view

CONFUSING MESSAGES FROM GUIDELINES AND THE HYPERTENSION TREATMENT TRIALS - Percentage of Type 2 Diabetic Patients with End-Stage Renal Disease in the RENAAL Study ... End-Stage Renal Disease (%) 0 12 24 36 48. 30. 20. 10. 0. Placebo ...

Percentage of Type 2 Diabetic Patients with End-Stage Renal Disease in the RENAAL Study ... End-Stage Renal Disease (%) 0 12 24 36 48. 30. 20. 10. 0. Placebo ...

| PowerPoint PPT presentation | free to view

HTN & CHD - Athanasios J. Manolis MD Cardiovascular disease: the leading cause of death worldwide Hypertension Syndrome ...

Athanasios J. Manolis MD Cardiovascular disease: the leading cause of death worldwide Hypertension Syndrome ...

| PowerPoint PPT presentation | free to view

Management of Coronary Artery Disease: PowerPoint PPT Presentation

Management of Coronary Artery Disease: - CHD is the leading cause of death in adults in US (1/3 of all deaths in subjects ... ACC/AHA Post-MI Guideline, BHAT, SAVE, Capricorn, EPHESUS. Post-MI ...

CHD is the leading cause of death in adults in US (1/3 of all deaths in subjects ... ACC/AHA Post-MI Guideline, BHAT, SAVE, Capricorn, EPHESUS. Post-MI ...

| PowerPoint PPT presentation | free to view

The JNC 7 recommendations for PowerPoint PPT Presentation

The JNC 7 recommendations for - * The amlodipine group had a 38% higher risk of HF (p

* The amlodipine group had a 38% higher risk of HF (p

| PowerPoint PPT presentation | free to view

Manejo Integral de la Insuficiencia Renal Crnica PowerPoint PPT Presentation

Manejo Integral de la Insuficiencia Renal Crnica - Capacidad para identificar los pacientes en riesgo ... Objetivo Primario Compuesto (%) N en Riesgo. Terapia Convencional. Terapia Intensiva ...

Capacidad para identificar los pacientes en riesgo ... Objetivo Primario Compuesto (%) N en Riesgo. Terapia Convencional. Terapia Intensiva ...

| PowerPoint PPT presentation | free to view

Hypertension: Which Drug? Psirropoulos Dimitrios Z, MD, PhD PowerPoint PPT Presentation

Hypertension: Which Drug? Psirropoulos Dimitrios Z, MD, PhD - Hypertension: Which Drug? Psirropoulos Dimitrios Z, MD, PhD Head Director, Cardiology Department & CCU G. Gennimatas General Hospital Thessaloniki, Greece

Hypertension: Which Drug? Psirropoulos Dimitrios Z, MD, PhD Head Director, Cardiology Department & CCU G. Gennimatas General Hospital Thessaloniki, Greece

| PowerPoint PPT presentation | free to view

Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and S PowerPoint PPT Presentation

Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and S - Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, ... pressure control and may occur regardless of whether albuminuria is present. ...

Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, ... pressure control and may occur regardless of whether albuminuria is present. ...

| PowerPoint PPT presentation | free to view

The story of man PowerPoint PPT Presentation

The story of man - The story of man .. The short version God populated the earth with broccoli, cauliflower and spinach green & yellow vegetables of all kinds ...

The story of man .. The short version God populated the earth with broccoli, cauliflower and spinach green & yellow vegetables of all kinds ...

| PowerPoint PPT presentation | free to download

Over the next 24 hours PowerPoint PPT Presentation

Over the next 24 hours - ... 20-year follow-up of 117,629 women. Hu FB, et al. Diabetes Care. ... 55 yr for men, 65 ... Survival Curves For. CV Mortality. Overall: P .001. C. B. A ...

... 20-year follow-up of 117,629 women. Hu FB, et al. Diabetes Care. ... 55 yr for men, 65 ... Survival Curves For. CV Mortality. Overall: P .001. C. B. A ...

| PowerPoint PPT presentation | free to view

Diabetes and Renal Disease PowerPoint PPT Presentation

Diabetes and Renal Disease - Type 1 Vs Type 2 DM. 4. Type 1. Young. Thin. Insulin deficient (pancr. islet cell loss) ... Immune destruction of insulin producing cells in pancreas. leading ...

Type 1 Vs Type 2 DM. 4. Type 1. Young. Thin. Insulin deficient (pancr. islet cell loss) ... Immune destruction of insulin producing cells in pancreas. leading ...

| PowerPoint PPT presentation | free to view

Idnt PowerPoint PPT Presentations